Nel, ASAs

Nel ASA's 224% Order Surge Overshadowed by Widening Losses, CEO Exit, and Zero Analyst Support

Published on 07/16/2026 at 18:24 | Redaktion boerse-global.de

Nel ASA's Q2 2026: order intake surges 224% to €20.5M, yet revenue drops 12% and loss deepens. CEO Volldal departs. Cash pile of €118.6M sustains operations. Stock declines 2.6%.

Nel ASA Q2 2026: Orders Soar 224% but Revenue Slips, CEO Departs
Nel ASA's 224% Order Surge Overshadowed by Widening Losses, CEO Exit, and Zero Analyst Support Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

Nel ASA’s second-quarter 2026 results read like a study in contradictions. The Norwegian hydrogen technology group booked orders worth €20.5 million — a 224% leap from the same period last year and the strongest intake in recent memory. Yet revenue slumped 12% to €13.7 million, the operating loss deepened to €18.3 million, and the company announced the departure of CEO Håkon Volldal. The market response has been tepid: the stock closed at €0.1948 on Thursday, down 2.6% on the day and about 47% below its 52-week high of €0.3655 set in late May.

The order explosion was almost entirely driven by Nel’s PEM electrolysis division, which accounted for 96% of new bookings. The segment’s order backlog swelled to €88.4 million, offering a promising pipeline for future quarters. However, the revenue benefit will lag, and the income statement for Q2 bore the brunt of a €6.3 million charge related to a settlement with Japanese partner Iwatani. That one-off item pushed EBITDA from a loss of €7.7 million a year ago to minus €13.8 million. The net loss settled at €16.9 million.

Cash cushion keeps the lights on

Despite the red ink, Nel’s balance sheet remains a source of comfort. Cash and equivalents stood at €118.6 million (1,328 million Norwegian kroner), down from 1,928 million NOK a year earlier but still ample to fund operations and investments. Management has stressed that liquidity is sufficient to weather the current trough in demand and to continue developing next-generation technology.

That assertion matters because the analyst community has turned conspicuously cold. Of the thirteen analysts covering the stock, none rate it a buy. Seven recommend selling, and six advise holding — a unanimity of caution that underscores how far Nel is from convincing the Street of a turnaround.

Should investors sell immediately? Or is it worth buying Nel ASA?

New electrolyser platform as a potential game-changer

What could shift that perception is the company’s new pressurized alkaline (PA) electrolyser platform, launched on May 6 with partners and customers. Early prototypes have delivered encouraging results, according to Nel. The design cuts footprint by 80% and capital expenditure by 40–60%. Management expects initial orders in the coming months and is scaling production capacity with the help of a €135 million EU grant: 500 megawatts by end-2026 and 1 gigawatt in 2027.

Profitability, however, remains a distant target. Nel has stated it needs annual alkaline volumes in the triple-digit megawatt range coupled with a PEM utilization rate of 20–24% to break even. By those measures, the company is still far short of the threshold — hence the critical importance of the cash pile.

Segment-level performance paints a mixed picture

The PEM division posted revenue of 97 million NOK (roughly €8.6 million), up 31% from the first quarter but down 10% year-on-year, carried mainly by small kilowatt-scale electrolysers. The alkaline segment saw a 14% revenue decline versus Q2 2025, though its EBITDA remained stable. Together, the two businesses generated an operating loss of 205 million NOK (€18.3 million), in line with the cumulative loss reported in euros.

Nel ASA at a turning point? This analysis reveals what investors need to know now.

Technical signals flash caution

The stock’s chart reflects the market’s ambivalence. It trades 22.5% below its 50-day moving average of €0.2560 and 7.9% below the 200-day average of €0.2154. The 14-day relative strength index at 32.4 hovers near oversold territory, and 30-day annualized volatility of 51.2% points to sharp swings on any fresh news. Over the past week the shares have lost 3.7%; over a month, 8.2%. Yet year-to-date they are still up 3.5%, a reminder of the two-way risk in a name that remains a bet on hydrogen adoption, not on current earnings.

With a leadership vacuum at the top, zero analyst conviction, and a settlement-driven loss that masks a fundamentally stable underlying business, Nel ASA enters the second half of 2026 leaning heavily on its cash buffer and the promise of a new platform. Whether the order momentum translates into revenue growth — and eventually profitability — will determine if the stock can claw back the ground it has lost since May.

Ad

Nel ASA Stock: New Analysis - 16 July

Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nel ASA analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | NO0010081235 | NEL | boerse | 69781495 |